-
Kanjana Srisutthisamphan
- Back
List of Publications
SCOPUS (5)- Preclinical evaluation of immunogenicity, efficacy and safety of a recombinant plant-based SARS-CoV-2 RBD vaccine formulated with 3M-052-Alum adjuvant (73 views)
- Immunogenicity and adverse events of priming with inactivated whole SARS-CoV-2 vaccine (CoronaVac) followed by boosting the ChAdOx1 nCoV-19 vaccine (60 views)
- A single V672F substitution in the spike protein of field-isolated PEDV Promotes Cell–Cell fusion and replication in Vero E6 cells (98 views)
- A single-cycle influenza a virus-based sars-cov-2 vaccine elicits potent immune responses in a mouse model (96 views)
- Pedv orf3 independently regulates i?b kinase ?-mediated nf-?b and ifn-? promoter activities (145 views)
List of Publications
WOS (19)- Immunogenicity and reactogenicity of fractional heterologous primary COVID-19 vaccination schedules with BNT162b2 boosters in 5�-year-old Thai children A multicenter prospective double-blind randomized control trial (29 views)
- Phase II prefusion non-stabilised Covid-19 mRNA vaccine randomised study (35 views)
- Assessment of safety and intranasal neutralizing antibodies of HPMC-based human anti-SARS-CoV-2 IgG1 nasal spray in healthy volunteers (21 views)
- Immunogenicity and Reactogenicity of Messenger RNA Coronavirus Disease 2019 Vaccine Booster Administered by Intradermal or Intramuscular Route in Thai Older Adults (34 views)
- Immunogenicity and reactogenicity of accelerated regimens of fractional intradermal COVID-19 vaccinations (44 views)
- Human BST2 inhibits rabies virus release independently of cysteine-linked dimerization and asparagine-linked glycosylation (23 views)
- SARS-CoV-2 Delta (B.1.617.2) variant replicates and induces syncytia formation in human induced pluripotent stem cell-derived macrophages (47 views)
- SARS-CoV-2 Delta (B.1.617.2) variant replicates and induces syncytia formation in human induced pluripotent stem cell-derived macrophages (44 views)
- Impact of mAb-induced A475V substitution on viral fitness and antibody neutralization of SARS-CoV-2 omicron variants in the presence of monoclonal antibodies and human convalescent sera (105 views)
- Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults (76 views)
- Chimeric Virus-like Particle-Based COVID-19 Vaccine Confers Strong Protection against SARS-CoV-2 Viremia in K18-hACE2 Mice (103 views)
- A recombinant subunit vaccine candidate produced in plants elicits neutralizing antibodies against SARS-CoV-2 variants in macaques (56 views)
- Receptor binding domain proteins of SARS-CoV-2 variants produced in Nicotiana benthamiana elicit neutralizing antibodies against variants of concern (57 views)
- In Vitro and In Vivo Attenuation of Vesicular Stomatitis Virus (VSV) by Phosphoprotein Deletion (79 views)
- The Pilot Study of Immunogenicity and Adverse Events of a COVID-19 Vaccine Regimen: Priming with Inactivated Whole SARS-CoV-2 Vaccine (CoronaVac) and Boosting with the Adenoviral Vector (ChAdOx1 nCoV-19) Vaccine (72 views)
- PEDV ORF3 Independently Regulates I kappa B Kinase beta-Mediated NF-kappa B and IFN-beta Promoter Activities (73 views)
- Cross-Neutralization of SARS-CoV-2-Specific Antibodies in Convalescent and Immunized Human Sera against the Bat and Pangolin Coronaviruses (85 views)
- Characterization of influenza A virus pseudotyped with the spike protein of porcine epidemic diarrhea virus (69 views)
- A Single V672F Substitution in the Spike Protein of Field-Isolated PEDV Promotes Cell-Cell Fusion and Replication in VeroE6 Cells (98 views)